RBC Capital Downgrades NeuBase Therapeutics (NBSE) to Sector Perform Oct 18, 2022 05:23AM
NeuBase Therapeutics to Participate in Upcoming Investor Conferences in May 2021 May 14, 2021 12:30PM
NeuBase Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Apr 26, 2021 04:01PM
NeuBase Therapeutics (NBSE) Prices $40 Million Public Offering of Common Stock at $5/sh Apr 22, 2021 09:09AM
NeuBase Therapeutics Announces Pricing of $40 Million Public Offering of Common Stock Apr 22, 2021 09:07AM


Apr 21, 2021 04:01PM NeuBase Therapeutics (NBSE) Announces Proposed Public Offering of Common Stock
Apr 21, 2021 04:01PM NeuBase Therapeutics Announces Proposed Public Offering of Common Stock
Jun 16, 2020 05:20AM RBC Capital Starts NeuBase Therapeutics (NBSE) at Outperform
May 11, 2020 08:00AM NeuBase Therapeutics to Present at Upcoming Investor Conferences in May 2020